Revivocell

We develop complex in vitro models to address multiple issues associated with drug discovery in the pharmaceutical industry. Our mission is divided into 3 objectives – read on to learn more. At Revivocell, Abdullah designs and implements research plans for Liver models on Organ-On-A-Chip platforms, aiming to advance drug discovery and toxicity assessment. Dr Ahtasham Raza enriches Revivocell with interdisciplinary expertise in 3D soft tissue engineering, bioimaging, and drug discovery. Learn about Revivocell's CELLBLOKS® technology, a modular multi-organ/cell type co-culture system that bridges the gap between traditional methods and organs-on-a-chip approaches. We focus on creating realistic in vitro models to provide pharmaceutical companies with superior preclinical data. Through the development of realistic in vitro models, we believe we can reduce the reliance on animals for preclinical testing of pharmaceutical compounds. We will deliver in a timely manner on mutually agreed deadlines.